Kubilay Karsidag

Kubilay Karsidag

Auto-generated profile, based on publicly available information

Kubilay Karsidag

Istanbul University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2011 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
VLVicky Lehmann
Vicky Lehmann
CMCeylan Makine
Ceylan Makine
ÇKÇagatay Karşıdağ
Çagatay Karşıdağ
PKPınar Kadıoğlu
Pınar Kadıoğlu
KKKubilay Karşıdağ
Kubilay Karşıdağ
FPFrançois Pouwer
François Pouwer
Background: Depression is a common co-morbid health problem in patients with diabetes that is underrecognised. Current international guidelines recommend screening for depression in patients with diabetes. Yet, few depression screening instruments have been validated for use in this particular group of patients. Aim of the present study was to investigate the psychometric properties of the Turkish version of the Centre for Epidemiologic Studies Depression Scale (CES-D) in patients with type 2 diabetes.Methods: A sample of 151 Turkish outpatients with type 2 diabetes completed the CES-D, the World Health Organization-Five Well-Being Index (WHO-5), and the Problem Areas in Diabetes scale (PAID). Explanatory factor analyses, various correlations and Cronbach's alpha were investigated to test the validity and reliability of the CES-D in Turkish diabetes outpatients.Results: The original four-factor structure proposed by Radloff was not confirmed. Explanatory factor analyses revealed a two-factor structure representing two subscales: (1) depressed mood combined with somatic symptoms of depression and (2) positive affect. However, one item showed insufficient factor loadings. Cronbach's alpha of the total score was high (0.88), as were split-half coefficients (0.77-0.90). The correlation of the CES-D with the WHO-5 was the strongest (r = -0.70), and supported concurrent validity.Conclusion: The CES-D appears to be a valid measure for the assessment of depression in Turkish diabetes patients. Future studies should investigate its sensitivity and specificity as well as test-retest reliability.

12 December 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BYBetul Yigit Yalcın
Betul Yigit Yalcın
ÜMÜmmü Mutlu
Ümmü Mutlu
AKAyşe Merve Ok Kurt
Ayşe Merve Ok Kurt
OCOzge Telci Caklili
Ozge Telci Caklili
HHHulya Hacisahinogullari
Hulya Hacisahinogullari
KKKubilay Karsidag
Kubilay Karsidag
Gestational diabetes mellitus (GDM) is a prevalent condition requiring accurate patient education, yet the reliability and readability of large language models (LLMs) in this context remain uncertain. This study evaluated the performance of four LLMs—ChatGPT-4o, Gemini 2.5 Pro, Grok 3.0, and DeepSeek R-1—using 25 patient-oriented questions derived from clinical scenarios. Seven endocrinologists independently rated the responses with the modified DISCERN (mDISCERN) instrument and the Global Quality Score (GQS). Readability was analyzed using the Flesch Reading Ease (FRES), Flesch–Kincaid Grade Level (FKGL), Gunning Fog Index (GFI), Coleman–Liau Index (CLI), and Simple Measure of Gobbledygook (SMOG), while lexical diversity was assessed through type–token ratio (TTR). Grok and Gemini obtained the highest mDISCERN and GQS scores, whereas ChatGPT performed significantly lower (p < 0.05). DeepSeek generated the most readable outputs, while Grok provided the longest and most complex responses. All models scored below the FRES threshold of 60 recommended for lay audiences. Response length showed strong positive correlations with mDISCERN and GQS, while TTR was inversely related to quality but positively associated with readability. These findings highlight variability among LLMs in GDM education and emphasize the need for model-specific improvements to ensure reliable patient-facing health information.

4 September 2023 in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
Verified
Journal Article
Open access
PDF file
YAyasemin atik altinok
yasemin atik altinok
BTBeyza Eliuz Tipici
Beyza Eliuz Tipici
IIIdiz Idiz
Idiz Idiz
SÖSu ÖZGÜR
Su ÖZGÜR
AKAyşe Merve Ok Kurt
Ayşe Merve Ok Kurt
KKKubilay Karşıdağ
Kubilay Karşıdağ
Background and objective: Although many studies on the Diabetes Eating Problem Survey–Revised (DEPS-R) in adolescents with type 1 diabetes mellitus (T1D), the number of studies validating this questionnaire in adults with T1D is limited. Therefore, this study aimed to examine the factor structure of the Turkish version of the DEPS-R in adults with T1D and internal consistency and construct validity. Methods: A total of 100 patients with T1D, ages 18–50 years, completed the DEPS-R and EDE-Q. In addition to tests of validity, confirmatory factor analysis was conducted to investigate the factor structure of the 6-item Turkish version of DEPS-R. Results: The Cronbach’s alpha coefficient of the DEPS-R Turkish version was 0.77, suggesting good internal consistency. The median (IQ) DEPS-R score was 15.0 (13.0) among all participants. DEPS-R score was significantly correlated with BMI (r = 0.210; p < 0.05) and EDE-Q (r = 0.586; p < 0.01). There was no correlation between the HbA1c values of participants and neither EDE-Q nor DEPS-R scores. The confirmatory factor analysis results show that the three-factor model was a good fit. Conclusion: A short, self-administered diabetes-specific screening tool for disordered eating behavior is recommended be used routinely in the clinical care of adults with T1D, and Turkish version of DEPS-R has acceptable internal consistency and construct validity in adults with T1D. Level of evidence: Level V, descriptive study. Clinicaltrials.gov registration number NCT05346679/ 21.04.2022 (retrospectively registered)

4 August 2025 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
NNNeeraj Narula
Neeraj Narula
EWEmily C.L. Wong
Emily C.L. Wong
AMAndrew Mente
Andrew Mente
SRSumathy Rangarajan
Sumathy Rangarajan
XLXinyue Lang
Xinyue Lang
SYSalim Yusuf
Salim Yusuf
INTRODUCTION: Ultraprocessed grains, commonly consumed in Western diets, undergo refining processes that often remove beneficial components and include additives to enhance taste, texture, or durability, potentially influencing gastrointestinal health. This study examines the association between ultraprocessed grain consumption and the risk of developing inflammatory bowel disease (IBD) using data from the Prospective Urban Rural Epidemiology (PURE) study. METHODS: This analysis included 124,590 participants from 21 countries who had dietary data available in the PURE study. Dietary intake was assessed through validated food frequency questionnaires, and ultraprocessed grain intake was categorized into 3 levels. The primary outcome was the development of IBD, including Crohn's disease (CD) and ulcerative colitis (UC). Multivariate Cox proportional hazard models were used to calculate hazard ratios (HRs), adjusting for confounders including age, sex, smoking status, eating habits, and physical activity. RESULTS: Among 124,590 participants, higher ultraprocessed grain intake was associated with increased IBD risk. Participants consuming ≥19 g/d of ultraprocessed grains had a higher risk of developing IBD compared with those consuming <9 g/d (hazard ratio [HR] 1.86, 95% confidence interval 1.26–2.61, P trend = 0.0003) after multivariate adjustment. Fresh bread and rice consumption were associated with lower IBD risk. Participants with greater ultraprocessed food intake (≥5 servings per day) were linked to a higher risk of developing IBD compared with those consuming <1 serving per day (HR 3.95, 95% confidence interval 2.74–5.71, P trend < 0.0001). DISCUSSION: Higher intake of ultraprocessed grains is associated with significantly increased risk of developing IBD. A healthy eating pattern should minimize consumption of ultraprocessed grains. Further studies should be performed to understand which components of ultraprocessed grains may be detrimental for health.

8 August 2025 in Medicina
Verified
Journal Article
Open access
PDF file
YÇYunus Çatma
Yunus Çatma
AEAhmed Edizer
Ahmed Edizer
OBOsman Faruk Bayramlar
Osman Faruk Bayramlar
NGNurdan Gul
Nurdan Gul
ÖSÖzlem Soyluk Selçukbiricik
Özlem Soyluk Selçukbiricik
AUAyşe Kubat Uzum
Ayşe Kubat Uzum
Background and Objectives: Thyroid dysfunction (TD) is more frequently observed in patients with diabetes mellitus (DM) compared to the general population. This study aims to determine the prevalence of TD in a large cohort of patients diagnosed with type 2 diabetes mellitus (T2DM) and to evaluate its possible impact on glycemic control, comorbidities, and diabetes-related complications. Materials and Methods: A total of 723 patients with type 2 diabetes mellitus (47.9% female, 52.1% male) were retrospectively evaluated. Demographic information of the patients, comprehensive history including onset and duration of DM and also comorbid diseases, diabetes-related complications, laboratory results, antidiabetic drugs and presence of TD were recorded and analyzed. Results: The prevalence of TD was 21.4% in 723 patients. Dyslipidemia was the most common comorbidity (63.6%). Patients with TD had significantly higher baseline BMI and longer diabetes duration (p = 0.007 and p = 0.048, respectively). Overall complication and comorbidity rates were 80.1% and 66%. TD was more common in females (73.4% vs. 26.6%; p < 0.001). Hypertension (69.5% vs. 58.7%) and neuropathy (40.9% vs. 33.0%) were significantly more frequent in the TD group (p < 0.05 for both). The total comorbidity rate was also higher in TD-positive patients (72.7% vs. 64.1%; p = 0.046). A significant positive correlation was observed between BMI and TSH levels. Conclusions: The increased prevalence of TD in patients with T2DM was clearly demonstrated. Female gender was identified as an independent risk factor, while elevated BMI and longer diabetes duration showed significant associations with TD status. The coexistence of TD and T2DM may contribute to a higher risk of diabetic complications and comorbidities. Routine screening of thyroid function is recommended to enable early identification and improve the overall clinical management.

1 January 2023 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
AOAytekin Oǧuz
Aytekin Oǧuz
MKMustafa Kilickap
Mustafa Kilickap
SGSadi Gulec
Sadi Gulec
YAYueksel Altuntas
Yueksel Altuntas
KKKubilay Karsidag
Kubilay Karsidag
SYSalim Yusuf
Salim Yusuf
Background: The risk of cardiovascular disease is correlated with the frequency and control of associated risk factors in diabetes mellitus and may vary according to country. We evaluated risk factors for cardiovascular disease, cardiovascular events, and the use of preventive medications in patients with diabetes mellitus using the Prospective Urban and Rural Epidemiological Turkiye cohort.Methods: Patients with diabetes mellitus versus without diabetes mellitus were com- pared for risk factors, cardioprotective drugs (angi otens in-co nvert ing enzyme inhibitors or angiotensin-II receptor antagonists, statins, and antiplatelets), and cardiovascular events. The primary outcome was major cardiovascular events (composite of cardiovas- cular death, myocardial infarction, stroke, or heart failure).Results: Among 4041 participants, 549 (13.6%) had diabetes mellitus. The mean age (54.8 & PLUSMN;8.4 vs. 49.3 & PLUSMN; 9.0 years, P < .001) and proportion of women (65.4% vs. 59.9%, P = .014) were higher in diabetics compared with non-diabetics. Hypertension, history of coronary heart disease, and use of statin, antiplatelets, and angiotensin-converting enzyme inhibitors or angiotensin-II receptor antagonists were more common in diabetics; however, the use of these medications at baseline was lower than optimal even in patients with diabetes mellitus and concomitant coronary heart disease (statin 31.2%, antiplatelets 46.9%, and angiotensin-converting enzyme inhibitors or angiotensin-II receptor antagonists 54.7%). During 11.5 years of follow-up, major cardiovascular events occurred in 288 (7.1%) patients, and the risk was higher in diabetics [hazard ratio (95% confidence interval) 1.71 (1.30-2.24); P < .001]. The increase in the risk of future events was comparable for those with diabetes mellitus alone without cardiovascular disease [hazard ratio 1.62 (1.20-2.20)] versus those with cardiovascular disease alone without diabetes mellitus [hazard ratio 1.31 (0.83-2.07)] and was additive in those with both conditions [hazard ratio 2.79 (1.65-4.69)]. The risk of major coronary events (myocardial infarction, angina, percutaneous, or surgical coronary intervention) was also higher in diabetes mellitus [hazard ratio 1.64 (1.26-2.15); P < .001].Conclusion: Patients with diabetes mellitus have a higher risk of major cardiovascular events, and the risk is comparable to that observed in those with cardiovascular disease but no diabetes mellitus. The use of preventive medicines for cardiovascular diseases is disturbingly low in diabetics.